226 related articles for article (PubMed ID: 37749267)
1. Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses.
Wang M; Rousseau B; Qiu K; Huang G; Zhang Y; Su H; Le Bihan-Benjamin C; Khati I; Artz O; Foote MB; Cheng YY; Lee KH; Miao MZ; Sun Y; Bousquet PJ; Hilmi M; Dumas E; Hamy AS; Reyal F; Lin L; Armistead PM; Song W; Vargason A; Arthur JC; Liu Y; Guo J; Zhou X; Nguyen J; He Y; Ting JP; Anselmo AC; Huang L
Nat Biotechnol; 2023 Sep; ():. PubMed ID: 37749267
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial Fusobacterium nucleatum-Mimicking Nanomedicine to Selectively Eliminate Tumor-Colonized Bacteria and Enhance Immunotherapy Against Colorectal Cancer.
Chen L; Zhao R; Shen J; Liu N; Zheng Z; Miao Y; Zhu J; Zhang L; Wang Y; Fang H; Zhou J; Li M; Yang Y; Liu Z; Chen Q
Adv Mater; 2023 Nov; 35(45):e2306281. PubMed ID: 37722134
[TBL] [Abstract][Full Text] [Related]
3. Comparative Analysis of Colon Cancer-Derived Fusobacterium nucleatum Subspecies: Inflammation and Colon Tumorigenesis in Murine Models.
Queen J; Domingue JC; White JR; Stevens C; Udayasuryan B; Nguyen TTD; Wu S; Ding H; Fan H; McMann M; Corona A; Larman TC; Verbridge SS; Housseau F; Slade DJ; Drewes JL; Sears CL
mBio; 2021 Feb; 13(1):e0299121. PubMed ID: 35130731
[TBL] [Abstract][Full Text] [Related]
4. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
[TBL] [Abstract][Full Text] [Related]
5.
Yin H; Miao Z; Wang L; Su B; Liu C; Jin Y; Wu B; Han H; Yuan X
Aging (Albany NY); 2022 Feb; 14(4):1941-1958. PubMed ID: 35212644
[TBL] [Abstract][Full Text] [Related]
6. Opportunistic detection of Fusobacterium nucleatum as a marker for the early gut microbial dysbiosis.
Huh JW; Roh TY
BMC Microbiol; 2020 Jul; 20(1):208. PubMed ID: 32660414
[TBL] [Abstract][Full Text] [Related]
7. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
8. Fusobacterium nucleatum promotes colon cancer progression by changing the mucosal microbiota and colon transcriptome in a mouse model.
Wu N; Feng YQ; Lyu N; Wang D; Yu WD; Hu YF
World J Gastroenterol; 2022 May; 28(18):1981-1995. PubMed ID: 35664967
[TBL] [Abstract][Full Text] [Related]
9. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
10. Fusobacterium nucleatum-derived succinic acid induces tumor resistance to immunotherapy in colorectal cancer.
Jiang SS; Xie YL; Xiao XY; Kang ZR; Lin XL; Zhang L; Li CS; Qian Y; Xu PP; Leng XX; Wang LW; Tu SP; Zhong M; Zhao G; Chen JX; Wang Z; Liu Q; Hong J; Chen HY; Chen YX; Fang JY
Cell Host Microbe; 2023 May; 31(5):781-797.e9. PubMed ID: 37130518
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Role of Gut Microbiome in Colon Cancer.
Chattopadhyay I; Dhar R; Pethusamy K; Seethy A; Srivastava T; Sah R; Sharma J; Karmakar S
Appl Biochem Biotechnol; 2021 Jun; 193(6):1780-1799. PubMed ID: 33492552
[TBL] [Abstract][Full Text] [Related]
12. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
13. Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening.
Leung A; Tsoi H; Yu J
Expert Rev Gastroenterol Hepatol; 2015 May; 9(5):651-7. PubMed ID: 25582922
[TBL] [Abstract][Full Text] [Related]
14. Gut Microbiota in Colorectal Cancer: Biological Role and Therapeutic Opportunities.
Pandey H; Tang DWT; Wong SH; Lal D
Cancers (Basel); 2023 Jan; 15(3):. PubMed ID: 36765824
[TBL] [Abstract][Full Text] [Related]
15. The Role of Fusobacterium nucleatum in Colorectal Carcinogenesis.
Datorre JG; de Carvalho AC; Guimarães DP; Reis RM
Pathobiology; 2021; 88(2):127-140. PubMed ID: 33291114
[TBL] [Abstract][Full Text] [Related]
16. Diet-mediated gut microbial community modulation and signature metabolites as potential biomarkers for early diagnosis, prognosis, prevention and stage-specific treatment of colorectal cancer.
John Kenneth M; Tsai HC; Fang CY; Hussain B; Chiu YC; Hsu BM
J Adv Res; 2023 Oct; 52():45-57. PubMed ID: 36596411
[TBL] [Abstract][Full Text] [Related]
17. Association between colorectal cancer and Fusobacterium nucleatum and Bacteroides fragilis bacteria in Iranian patients: a preliminary study.
Shariati A; Razavi S; Ghaznavi-Rad E; Jahanbin B; Akbari A; Norzaee S; Darban-Sarokhalil D
Infect Agent Cancer; 2021 Jun; 16(1):41. PubMed ID: 34108031
[TBL] [Abstract][Full Text] [Related]
18. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls.
Senthakumaran T; Moen AEF; Tannæs TM; Endres A; Brackmann SA; Rounge TB; Bemanian V; Tunsjø HS
Eur J Clin Microbiol Infect Dis; 2023 Mar; 42(3):305-322. PubMed ID: 36703031
[TBL] [Abstract][Full Text] [Related]
19. Relationship between Fusobacterium nucleatum and antitumor immunity in colorectal cancer liver metastasis.
Sakamoto Y; Mima K; Ishimoto T; Ogata Y; Imai K; Miyamoto Y; Akiyama T; Daitoku N; Hiyoshi Y; Iwatsuki M; Baba Y; Iwagami S; Yamashita YI; Yoshida N; Komohara Y; Ogino S; Baba H
Cancer Sci; 2021 Nov; 112(11):4470-4477. PubMed ID: 34464993
[TBL] [Abstract][Full Text] [Related]
20. Escherichia coli Nissle 1917 Enhances Innate and Adaptive Immune Responses in a Ciprofloxacin-Treated Defined-Microbiota Piglet Model of Human Rotavirus Infection.
Michael H; Paim FC; Langel SN; Miyazaki A; Fischer DD; Chepngeno J; Amimo J; Deblais L; Rajashekara G; Saif LJ; Vlasova AN
mSphere; 2021 Mar; 6(2):. PubMed ID: 33789939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
